Thursday, July 30, 2026
spot_img
HomeDaily Market ReportDaily Market Report: July 6, 2026

Daily Market Report: July 6, 2026

Date:

Related stories

Daily Market Report: July 30, 2026

U.S. equity markets suffered their worst session in over...

Daily Market Report: July 29, 2026

U.S. markets delivered a split verdict as the Dow surged 537 points on strong earnings while semiconductor stocks extended their historic rout. With the Fed rate decision due Wednesday and Microsoft, Meta, Apple, and Amazon all reporting this week, investors face one of the most pivotal stretches of 2026.

Daily Market Report: July 28, 2026

Market Overview Global financial markets faced a turbulent start to...

Daily Market Report: July 23, 2026

U.S. equity markets closed mixed on Thursday, July 23,...

Daily Market Report: July 21, 2026

Market Overview U.S. equities began the week cautiously as investors...
spot_img

Traders working on the busy NYSE trading floor as the Dow Jones Industrial Average reaches record highs in July 2026
Traders on the New York Stock Exchange floor as the Dow climbs toward record territory. Photo: Pexels

Market Overview

U.S. equity markets closed out a strong holiday-shortened week ending July 3, 2026, with the Dow Jones Industrial Average leading the charge to fresh record highs. The Dow rose approximately 2.0% for the week, closing just under the psychologically significant 53,000 level — a milestone it has never previously reached. The S&P 500 gained 1.8% for the week, closing at 7,483.24, while the Nasdaq Composite advanced 2.1%. The Russell 2000 small-cap index also participated in the broader rally, reflecting improving market breadth across the capitalization spectrum.

The overarching theme of the week was a meaningful sector rotation away from semiconductor and AI hardware names toward cyclical and defensive sectors. Financials, Healthcare, and Industrials all closed at new weekly all-time highs, more than offsetting the consolidation in chip stocks. The VanEck Semiconductor ETF (SMH) shed 3.2%, marking its second consecutive losing week, yet broader indices held firm — a sign of underlying market resilience. As of Monday, July 6, U.S. markets are closed for the Independence Day holiday, with futures pointing to further gains when trading resumes Tuesday.

Market sentiment remains constructive heading into the second half of 2026. The S&P 500 is up approximately 9% year-to-date, and Wall Street strategists broadly maintain a bullish outlook. JPMorgan recently raised its year-end S&P 500 target to 7,800, citing earnings momentum and liquidity conditions. The advance/decline line and the percentage of S&P 500 constituents trading above their 200-day moving averages are both trending higher, confirming the breadth of the current bull market.

Top Market Movers

Axon Enterprise Surges on ICE Contract Attention

Axon Enterprise (AXON) surged approximately 28–34% during the week after federal disclosures revealed President Trump's personal stock holdings, drawing renewed investor attention to a pending ICE Taser contract. The company, which manufactures law enforcement technology including body cameras and conducted energy weapons, saw its shares spike as traders speculated on the potential contract value. Axon is one of the top-performing S&P 500 constituents year-to-date.

Investment implications: The Axon move underscores how government contract news and political disclosures can create sharp, short-term trading opportunities in defense and law enforcement technology stocks. Investors should monitor contract award announcements closely, as the actual ICE contract decision could serve as either a catalyst or a sell-the-news event.

Moderna Jumps on mRNA Platform Expansion Plans

Moderna (MRNA) jumped approximately 18–33% after the company's Science Day presentation outlined ambitious plans to expand its mRNA technology platform into oncology and autoimmune disease treatments. The announcement signaled a significant broadening of Moderna's commercial pipeline beyond its COVID-19 vaccine franchise, which has faced declining revenues in recent quarters.

Investment implications: Moderna's pipeline expansion into high-value therapeutic areas like cancer and autoimmune disease represents a potential re-rating catalyst for the stock. Investors should evaluate the clinical timelines and competitive landscape in these indications, as mRNA technology faces competition from established biologics manufacturers.

Memory Chip Stocks Tumble on Apple-China DRAM Reports

SanDisk (SNDK) fell 16.5% and Micron Technology (MU) declined 13.8% after reports emerged that Apple is lobbying Washington to source dynamic random-access memory (DRAM) from Chinese manufacturers CXMT and YMTC — both currently on the Pentagon's restricted entity list. The reports suggest the global memory chip shortage has become severe enough to push major buyers toward extreme sourcing measures, introducing fresh competitive pressure into the supply chain. Micron dropped approximately 19% over the full week.

Investment implications: The Apple-China DRAM story introduces a new geopolitical risk dimension for U.S. memory chip manufacturers. If Washington grants any exemptions or if Apple pursues alternative sourcing, it could structurally alter the competitive dynamics for SanDisk and Micron. Investors should watch for regulatory responses and any formal Apple supply chain announcements.

Meta Gains as AI Capacity Monetization Strategy Emerges

Meta Platforms (META) rose approximately 5.9% after the company announced plans to sell excess AI computing capacity to third parties, effectively monetizing its massive infrastructure investments. The move pressured neocloud providers such as CoreWeave, which compete in the AI compute rental market, while validating Meta's long-term AI infrastructure strategy.

Investment implications: Meta's pivot to monetizing AI infrastructure excess capacity represents a new revenue stream that could improve the return on its substantial capital expenditure program. This development reinforces the thesis that hyperscalers with large AI infrastructure investments may increasingly compete with pure-play cloud AI providers.

Financial analyst reviewing stock market charts on multiple monitors, analyzing economic data and market trends
A financial analyst monitors multiple screens displaying market data and economic indicators. Photo: Pexels

Economic Data & Fed Watch

The marquee economic release of the holiday-shortened week was the June nonfarm payrolls report, which came in significantly below expectations. U.S. employers added just 57,000 jobs in June, roughly half the consensus forecast of 110,000–115,000 and well below May's downwardly revised 129,000. The unemployment rate ticked down to 4.2% from 4.3%, though this reflected a decline in the labor force participation rate from 61.8% to 61.5% rather than genuine job creation strength. Average hourly earnings rose 4.4% year-over-year, suggesting wage pressures remain elevated despite the softer headline number.

The weak payrolls data had an immediate impact on Federal Reserve rate expectations. Year-end rate hike odds eased from 85% mid-week to approximately 77% by Friday, as softer labor market data tempered conviction in the Fed's hawkish trajectory. New Fed Chair Kevin Warsh, speaking at the ECB's annual Sintra forum, reiterated that markets expecting tolerance above the 2% inflation target “would be disappointed,” reaffirming the central bank's commitment to price stability. The Supreme Court's narrow procedural ruling preserving Governor Lisa Cook's position added a degree of institutional stability, though it left underlying questions about Fed independence unresolved.

In the bond market, the 10-year Treasury yield stood at 4.49% as of the close on July 2, up 1 basis point on the day. The U.S. dollar posted a weekly loss following the soft payrolls print, as thinner holiday trading conditions amplified the currency's move lower. The dollar index's decline provided modest relief for emerging market currencies and commodities priced in dollars. This week's key focus will be the FOMC minutes from the June 16–17 meeting — the first under Chair Warsh — due Wednesday, which will provide the first detailed look at the committee's deliberations under new leadership.

Investment implications: The combination of a softer jobs market and a Fed committed to its 2% inflation target creates a nuanced environment for fixed income. Treasury yields may face modest downward pressure if upcoming data confirms a labor market slowdown, but the Fed's hawkish rhetoric limits the extent of any rally in bonds. Equity investors should monitor the FOMC minutes carefully for any signals about the pace and magnitude of potential rate adjustments.

International Markets

Asian equity markets traded mixed on Monday, July 6, as investors reassessed AI-driven investment themes. Japan's Nikkei 225 fell 0.7%, while the broader Topix added 0.2%. South Korea's Kospi declined 0.91% as the AI hardware selloff weighed on the tech-heavy index. The Hang Seng Index rebounded 3.0% last week, closing at 23,350, outperforming regional peers as Hong Kong's IPO market showed continued strength and healthcare stocks rallied. CSPC Pharmaceutical surged 19.6% after AstraZeneca signed a licensing deal worth up to $1.77 billion for kidney-disease drug candidates. BYD rose 15.8% after Q2 delivery data showed the company reclaiming the global lead in battery-electric vehicle sales from Tesla.

In Europe, markets were set to open slightly lower on Monday. The Eurozone composite PMI returned to expansion territory in June, rising to 50.0 from 48.5 in May, providing a modest positive signal for the regional economy. The Japanese yen weakened to a 40-year low near 162.8 per U.S. dollar before rebounding approximately 1% as speculators trimmed short positions on intervention risk. Japan's Q2 large manufacturing sentiment index surprised to the upside, jumping to +22 from +17, the best reading since 2018. China's official manufacturing PMI rose to 50.3 in June, marking a third straight month of expansion driven by high-tech exports tied to the AI boom.

Looking Ahead

The week of July 7–11 brings a concentrated slate of economic data and the unofficial start of Q2 earnings season. On Monday, July 7, investors will receive the S&P Global U.S. Composite PMI final reading for June, followed by the ISM Services PMI — a critical gauge of whether the services sector, which accounts for the majority of U.S. economic activity, is keeping pace with AI-driven growth. Consensus estimates for the ISM Services PMI are in the range of 54.0–54.2, which would signal continued expansion.

The most anticipated event of the week is the release of the FOMC minutes from the June 16–17 meeting on Wednesday. This will be the first detailed look at deliberations under new Fed Chair Kevin Warsh, who notably opted out of the dot plot — signaling his preference for a different communication approach. Markets will scrutinize the minutes for the balance of views between committee members concerned about sticky inflation and those more focused on labor market vulnerability. Additional U.S. data releases this week include trade figures, housing data, and weekly jobless claims.

On the earnings front, PepsiCo (PEP) reports on Thursday, July 9, opening the large-cap Q2 earnings season. Analysts expect earnings of approximately $2.21 per share on revenue of $24 billion. Delta Air Lines (DAL) follows on Friday, with results that will offer insight into consumer travel demand and airline industry health. Levi Strauss (LEVI) is also scheduled to report mid-week, providing a read on consumer apparel spending. Additionally, SpaceX is set to join the Nasdaq 100 this week, a significant index inclusion event that could drive passive fund flows into the stock. China's June CPI and PPI data will also be released, offering further clues on global inflation dynamics.

Disclaimer: This analysis is for informational and educational purposes only and should not be considered financial advice. Market conditions can change rapidly, and past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.

Latest stories

Subscribe Now

Subscription Form

By submitting, you agree to receive emails and/or  texts from Market WealthPro. Unsubscribe via email link. Text STOP to opt out. Msg & data rates may apply

spot_img

LEAVE A REPLY

Please enter your comment!
Please enter your name here

News From Our Partners

Stock AI vs. Top Human Traders

The AI that can forerecast 2,384 stock prices to the penny, days in advance

How The Rich Retire

How Mitt Romney turned $450k into up to $100 million (tax-free)

Trade This Elon Stock

This could be your only chance to claim a stake in Elon Musk's SpaceX

The NVIDIA Shock of 2026

Louis: I believe this new NVIDIA invention could mint a new wave of millionaires

AI Chip Trade is Out. This is In

Legendary investor outlines 3 steps to financially thrive in the coming months

“I Warned You About Elon Musk”

The man who called Tesla's 2,150% rise issues urgent tesla warning